We are live on ! Find out more
LBPS

4D Pharma PLC
LBPS

Delisted

LBPS was delisted on the 24th of June, 2022.

Back to rankings

8 hedge funds and large institutions have $2.67M invested in 4D Pharma PLC in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
+8
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UFM
Ursa Fund Management
California
+$1.85M
2
ACA
Apis Capital Advisors
New York
+$470K
3
Morgan Stanley
Morgan Stanley
New York
+$266K
4
AA
AQR Arbitrage
Connecticut
+$147K
5
CCM
Context Capital Management
California
+$60.1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UFM
1
Ursa Fund Management
California
$1.75M +$1.85M +148,098 New
ACA
2
Apis Capital Advisors
New York
$445K +$470K +37,657 New
Morgan Stanley
3
Morgan Stanley
New York
$253K +$266K +21,369 New
AA
4
AQR Arbitrage
Connecticut
$139K +$147K +11,767 New
CCM
5
Context Capital Management
California
$57K +$60.1K +4,820 New
Osaic Holdings
6
Osaic Holdings
Arizona
$17K +$18K +1,442 New
UBS Group
7
UBS Group
Switzerland
$11K +$11.4K +912 New
TRCT
8
Tower Research Capital (TRC)
New York
– +$100 +8 New

LBPS Hedge Fund Activity: Q1 2021 in Review

8 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC (LBPS) for Q1 2021, worth a combined $2.67M.

Buyers outnumbered sellers: 8 funds opened new LBPS positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Ursa Fund Management, opening a new position worth an estimated $1.85M.

  • 8 institutional investors held 4D Pharma PLC (LBPS) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $2.67M of 4D Pharma PLC stock for Q1 2021.
  • 8 funds opened new 4D Pharma PLC positions in Q1 2021 and 0 closed out, a net change of +8 holders.
  • The largest 4D Pharma PLC buyer in Q1 2021 was Ursa Fund Management, an estimated $1.85M added.

Based on aggregated 13F filings for Q1 2021.